Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

Open access
Tekpli, Xavier, Lien, Tonje, Røssevold, Andreas Hagen, Nebdal, Daniel, Borgen, Elin, Ohnstad, Hege Oma, Kyte, Jon Amund, Vallon-Christersson, Johan, Fongaard, Marie, Due, Eldri Undlien, Svartdal, Lisa Gregusson, Sveli, My Anh Tu, Garred, Øystein, OSBREAC, Børresen-Dale, Anne-Lise, Schlichting, Ellen, Sauer, Torill, Geisler, Jürgen, Hofvind, Solveig, Bathen, Tone F., Engebråten, Olav, Geitvik, Gry Aarum, Langerød, Anita, Kåresen, Rolf, Mælandsmo, Gunhild Mari, Lingjærde, Ole Christian, Skjerven, Helle Kristine, Park, Daehoon, Fritzman, Britt, Frigessi, Arnoldo, Sahlberg, Kristine Kleivi, Sørlie, Therese, Russnes, Hege G., Naume, Bjørn, Kristensen, Vessela N. · 2019 · Nature Communications

Abstract

How mixtures of immune cells associate with cancer cell phenotype and affect pathogenesis is still unclear. In 15 breast cancer gene expression datasets, we invariably identify three clusters of patients with gradual levels of immune infiltration. The intermediate immune infiltration cluster (Cluster B) is associated with a worse prognosis independently of known clinicopathological features. Furthermore, immune clusters are associated with response to neoadjuvant chemotherapy. In silico dissection of the immune contexture of the clusters identified Cluster A as immune cold, Cluster C as immune hot while Cluster B has a pro-tumorigenic immune infiltration. Through phenotypical analysis, we find epithelial mesenchymal transition and proliferation associated with the immune clusters and mutually exclusive in breast cancers. Here, we describe immune clusters which improve the prognostic accuracy of immune contexture in breast cancer. Our discovery of a novel independent prognostic factor in breast cancer highlights a correlation between tumor phenotype and immune contexture.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-13329-5

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 192

Metadata

Authors
Tekpli, X., Lien, T., Røssevold, A. H., Nebdal, D., Borgen, E., Ohnstad, H. O., Kyte, J. A., Vallon-Christersson, J., Fongaard, M., Due, E. U., Svartdal, L. G., Sveli, M. A. T., Garred, Ø., OSBREAC, Børresen-Dale, A.-L., Schlichting, E., Sauer, T., Geisler, J., Hofvind, S., Bathen, T. F., Engebråten, O., Geitvik, G. A., Langerød, A., Kåresen, R., Mælandsmo, G. M., Lingjærde, O. C., Skjerven, H. K., Park, D., Fritzman, B., Frigessi, A., Sahlberg, K. K., Sørlie, T., Russnes, H. G., Naume, B., & Kristensen, V. N.
Venue
Nature Communications
Published
2019-12-03
Volume
10
Issue
1
Pages
5499-5499
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2992466184
Cited by
192
References
12
FWCI
6.50
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. https://app.cochat.ai/papers/10.1038/s41467-019-13329-5
The paper
Tekpli, X., Lien, T., Røssevold, A. H., Nebdal, D., Borgen, E., Ohnstad, H. O., Kyte, J. A., Vallon-Christersson, J., Fongaard, M., Due, E. U., Svartdal, L. G., Sveli, M. A. T., Garred, Ø., OSBREAC, Børresen-Dale, A.-L., Schlichting, E., Sauer, T., Geisler, J., Hofvind, S., . . . Kristensen, V. N. (2019). An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nature Communications. https://doi.org/10.1038/s41467-019-13329-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.